Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Research

• Publication date

  2005-06-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1158/0008-5472.CAN-04-1817PMID 15930306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition.

  2005influential reference
• Pheophorbide a Is a Specific Probe for ABCG2 Function and Inhibition

  2004cited by this paper
• Mutations

  2004influential reference
• ABCG2 – a transporter for all seasons

  2004cited by this paper
• Structural mechanism of the simultaneous binding of two drugs to a multidrug‐binding protein

  2004cited by this paper
• Interaction of the breast cancer resistance protein with plant polyphenols.

  2004cited by this paper
• Phytoestrogens/Flavonoids Reverse Breast Cancer Resistance Protein/ABCG2-Mediated Multidrug Resistance

  2004cited by this paper
• Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport.

  2004cited by this paper
• Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2*

  2004cited by this paper
• Functional characterization of human breast cancer resistance protein (BCRP, ABCG2) expressed in the oocytes of Xenopus laevis.

  2003cited by this paper
• RU49953: a non-hormonal steroid derivative that potently inhibits P-glycoprotein and reverts cellular multidrug resistance

  2003cited by this paper
• Reversal of breast cancer resistance protein–mediated drug resistance by tryprostatin A

  2003cited by this paper
• Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

  2003cited by this paper
• Multiple flavonoid-binding sites within multidrug resistance protein MRP1

  2003cited by this paper
• Microplate Screening of the Differential Effects of Test Agents on Hoechst 33342, Rhodamine 123, and Rhodamine 6G Accumulation in Breast Cancer Cells that Overexpress P-Glycoprotein

  2002cited by this paper
• Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents.

  2002cited by this paper
• Role Reversal for Anticancer Agents

  2002cited by this paper
• Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.

  2002cited by this paper
• Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters

  2002cited by this paper
• Single-Nucleotide Polymorphism (SNP) Analysis in the ABC Half-Transporter ABCG2 (MXR/BCRP/ABCP1)

  2002cited by this paper
• Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.

  2001cited by this paper
• Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids.

  2001cited by this paper
• The Role of Half-Transporters in Multidrug Resistance

  2001cited by this paper
• A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).

  2001cited by this paper
• C-Isoprenylation of flavonoids enhances binding affinity toward P-glycoprotein and modulation of cancer cell chemoresistance.

  2001cited by this paper
• Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells.

  2001cited by this paper
• Correlation between Steady-state ATP Hydrolysis and Vanadate-induced ADP Trapping in Human P-glycoprotein

  2001cited by this paper
• Prenyl-flavonoids as potent inhibitors of the Pdr5p multidrug ABC transporter from Saccharomyces cerevisiae.

  2000cited by this paper
• The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.

  2000cited by this paper
• Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

  1999cited by this paper
• Correlation between the affinity of flavonoids binding to the cytosolic site of Leishmania tropica multidrug transporter and their efficiency to revert parasite resistance to daunomycin.

  1999cited by this paper
• MRP3, an organic anion transporter able to transport anti-cancer drugs.

  1999cited by this paper
• Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR.

  1999cited by this paper
• Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein.

  1998cited by this paper
• A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.

  1998cited by this paper
• Essential dynamics from NMR clusters: dynamic properties of the Myb DNA-binding domain and a hinge-bending enhancing variant.

  1998cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998cited by this paper
• Stimulation of ATPase Activity of Purified Multidrug Resistance-associated Protein by Nucleoside Diphosphates*

  1998cited by this paper
• Photoaffinity labeling of human P-glycoprotein: effect of modulator interaction and ATP hydrolysis on substrate binding.

  1998cited by this paper
• Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein.

  1997cited by this paper
• Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein.

  1997cited by this paper
• Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein

  1997cited by this paper
• Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.

  1995cited by this paper
• Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

  1992cited by this paper
• Inorganic and organic phosphate measurements in the nanomolar range.

  1987cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

  1976cited by this paper

• Identification of an N-methylpyrazole derivative as a selective inhibitor of breast cancer resistance protein (BCRP/ABCG2).

  2026cites this paper
• Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer

  2025cites this paper
• Selective Inhibition of the ABCG2 Transporter by Primaquine Derivatives Reverses the Multidrug Resistance of Tumor Cells

  2025cites this paper
• Cytotoxicity of β-carboline alkaloids isolated from Peganum harmala L. seeds on oxaliplatin resistant HCT116 cancer cells.

  2025cites this paper
• New players from the old chalcone scaffold: Synthesis, identification, and characterization of new potent ABCG2 inhibitors.

  2025cites this paper
• Natural products reverse cancer multidrug resistance

  2024cites this paper
• An Insight Review on Phytochemistry, Pharmacological Evidences, and Biosynthesis of Key Metabolites of Indian Himalayan Cherry (Prunus cerasoides Don.) with Emphasis on its Safety and Use in Tradtional Phytomedicine

  2024cites this paper
• pH regulators and their inhibitors in tumor microenvironment.

  2024cites this paper
• A review on phytochemicals as combating weapon for multidrug resistance in cancer

  2024cites this paper
• ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target?

  2024cites this paper
• Dietary flavonoid tectochrysin synergistically enhances cisplatin sensitivity on ovarian cancer cells through targeting the CDK1/cyclin B1 pathway

  2024cites this paper
• Marein, a novel natural product for restoring chemo-sensitivity to cancer cells through competitive inhibition of ABCG2 function.

  2024cites this paper
• Pinostrobin and Tectochrysin Conquer Multidrug-Resistant Cancer Cells via Inhibiting P-Glycoprotein ATPase

  2023influential citation
• An anti‐leishmanial compound 4′,7‐dihydroxyflavone elicits ROS‐mediated apoptosis‐like death in Leishmania parasite

  2023cites this paper
• Recent advances in BCRP‐induced breast cancer resistance treatment with marine‐based natural products

  2023cites this paper
• Mechanistic insights on anticancer drugs with specific biological targets and signalling pathways

  2023cites this paper
• Ethnopharmacological uses, pharmacological activities, and therapeutic applications of tectochrysin in Medicine: An important class of dietary flavonoid.

  2023cites this paper
• Pomiferin targets SERCA, mTOR, and P-gp to induce autophagic cell death in apoptosis-resistant cancer cells, and reverses the MDR phenotype in cisplatin-resistant tumors in vivo.

  2023cites this paper
• Analysis of Factors Affecting 5-ALA Fluorescence Intensity in Visualizing Glial Tumor Cells—Literature Review

  2022cites this paper
• Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.

  2022cites this paper
• Rationally Screened and Designed ABCG2-Binding Aptamers for Targeting Cancer Stem Cells and Reversing Multidrug Resistance.

  2022cites this paper
• Updated chemical scaffolds of ABCG2 inhibitors and their structure-inhibition relationships for future development.

  2022cites this paper
• Investigations with Drugs and Pesticides Revealed New Species- and Substrate-Dependent Inhibition by Elacridar and Imazalil in Human and Mouse Organic Cation Transporter OCT2

  2022cites this paper
• Selectively Halogenated Flavonolignans—Preparation and Antibacterial Activity

  2022cites this paper
• Hydroxygenkwanin Improves the Efficacy of Cytotoxic Drugs in ABCG2-Overexpressing Multidrug-Resistant Cancer Cells

  2022cites this paper
• A state-of-the-art review and prospective therapeutic applications of prenyl flavonoids as chemosensitizers against antifungal multidrug resistance in Candida albicans.

  2022cites this paper
• Flavonoids Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics

  2021cites this paper
• Mechanistic basis of breast cancer resistance protein inhibition by new indeno[1,2-b]indoles

  2021cites this paper
• Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance

  2021cites this paper
• Tectochrysin ameliorates murine allergic airway inflammation by suppressing Th2 response and oxidative stress.

  2021cites this paper
• LaPT2 Gene Encodes a Flavonoid Prenyltransferase in White Lupin

  2021cites this paper
• Polymethoxyflavones in Citrus Regulate Lipopolysaccharide-Induced Oscillating Decay of Circadian Rhythm Genes by Inhibiting Nlrp3 Expression

  2021cites this paper
• The role of dietary flavonoids for modulation of ATP binding cassette transporter mediated multidrug resistance

  2021influential citation
• Aframomum melegueta secondary metabolites exhibit polypharmacology against SARS‐CoV‐2 drug targets: in vitro validation of furin inhibition

  2020influential citation
• Flavones reversibly inhibit Leishmania donovani tyrosine aminotransferase by binding to the catalytic pocket: An integrated in silico-in vitro approach.

  2020cites this paper
• Inhibitory Effects of Quercetin and Its Main Methyl, Sulfate, and Glucuronic Acid Conjugates on Cytochrome P450 Enzymes, and on OATP, BCRP and MRP2 Transporters

  2020cites this paper
• Defying Multidrug Resistance! Modulation of Related Transporters by Flavonoids and Flavonolignans.

  2020cites this paper
• Enhancing Brain Retention of a KIF11 Inhibitor Significantly Improves its Efficacy in a Mouse Model of Glioblastoma

  2020cites this paper
• Antioxidant activity evaluation of rosemary ethanol extract and their cellular antioxidant activity toward HeLa cells.

  2019cites this paper
• Transcriptional plasticity of different ABC transporter genes from Tribolium castaneum contributes to diflubenzuron resistance.

  2019cites this paper
• Transporter-Mediated Drug-Drug Interactions and Their Significance.

  2019cites this paper
• Targeting multidrug resistance in cancer by natural chemosensitizers

  2019cites this paper
• Reversal of Multidrug Resistance in Cancer by Multi-Functional Flavonoids

  2019cites this paper
• Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2

  2019cites this paper
• Highly Cancer Selective Antiproliferative Activity of Natural Prenylated Flavonoids

  2018cites this paper
• Genistein-Specific G6DT Gene for the Inducible Production of Wighteone in Lotus japonicus

  2018cites this paper
• Pheophorbide A: Fluorescent Bcrp Substrate to Measure Oral Drug-Drug Interactions in Real-Time In Vivo

  2018cites this paper
• Synthesis of 5‐Hydroxy‐3′,4′,7‐trimethoxyflavone and Related Compounds and Elucidation of Their Reversal Effects on BCRP/ABCG2‐Mediated Anticancer Drug Resistance

  2018cites this paper
• Screening of prenyldiphosphate mimetics for their potential to inhibit 4-hydroxybenzoate oligoprenyl transferase

  2017cites this paper
• Synthesis, Crystal Structure and Antitumor Activity of Tectochrysin-6-sulfonate

  2017cites this paper
• In vitro evaluation of the pharmacokinetic effects of BCRP interactions

  2017cites this paper
• Fumitremorgins and Relatives - From Tremorgenic Compounds to Valuable Anti-Cancer Drugs.

  2017cites this paper
• In Vitro Evaluation of the Pharmacokinetic Effects of BCRP Interactions

  2017cites this paper
• Inhibition of Breast Cancer Resistance Protein and Multidrug Resistance Associated Protein 2 by Natural Compounds and Their Derivatives.

  2017cites this paper
• ABCG2/BCRP: Specific and Nonspecific Modulators

  2017cites this paper
• NVP‐TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P‐glycoprotein (PGP1) function

  2016cites this paper
• ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer

  2016influential citation
• Mechanisms of drug resistance in colon cancer and its therapeutic strategies.

  2016cites this paper
• Mass spectrometric characterization of flavonoids and in vitro intestinal transport and bioactivity

  2016cites this paper
• [Role of breast cancer resistance protein in drug disposition].

  2016cites this paper
• Breast Cancer Resistance Protein (ABCG2) in Clinical Pharmacokinetics and Drug Interactions: Practical Recommendations for Clinical Victim and Perpetrator Drug-Drug Interaction Study Design

  2015cites this paper
• A model of secreting murine mammary epithelial HC11 cells comprising endogenous Bcrp/Abcg2 expression and function

  2015cites this paper
• Classification of Breast Cancer Resistant Protein (BCRP) Inhibitors and Non-Inhibitors Using Machine Learning Approaches.

  2015cites this paper
• Strategies for drug delivery to the central nervous system by systemic route

  2015cites this paper
• Dual properties of hispidulin: antiproliferative effects on HepG2 cancer cells and selective inhibition of ABCG2 transport activity

  2015cites this paper
• Development of in-vitro human and rat proximal tubule cell models as a platform for drug transporter and drug-drug interaction studies

  2015cites this paper
• Transport Proteins in Mammary Epithelial Cells Studies in Murine ( HC 11 ) and Bovine ( BME-UV ) Cells – Effects of Prochloraz

  2015cites this paper
• SYNTHESIS OF COQ10, NONAPRENYL SULPHATES AND STUDIES OF ITS BIOLOGICAL ACTIVITIES

  2015cites this paper
• Marine Natural Products as Breast Cancer Resistance Protein Inhibitors

  2015cites this paper
• Flavonoid interactions during digestion, absorption, distribution and metabolism: a sequential structure–activity/property relationship-based approach in the study of bioavailability and bioactivity

  2015cites this paper
• Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance.

  2014cites this paper
• Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics

  2014cites this paper
• Symmetric bis-chalcones as a new type of breast cancer resistance protein inhibitors with a mechanism different from that of chromones.

  2014cites this paper
• Quinoxaline-substituted chalcones as new inhibitors of breast cancer resistance protein ABCG2: polyspecificity at B-ring position

  2014cites this paper
• BCRP Inhibition: from Data Collection to Ligand‐Based Modeling

  2014cites this paper
• Computational insights into the active site of human breast cancer resistance protein (BCRP/ABCG2): a similarity search approach

  2014cites this paper
• Determinants of the activity and substrate recognition of breast cancer resistance protein (ABCG2)

  2014influential citation
• MBL-II-141, a chromone derivative, enhances irinotecan (CPT-11) anticancer efficiency in ABCG2-positive xenografts

  2014cites this paper
• Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.

  2014cites this paper
• Flavone Induces Cell Death in Human Hepatoma HepG2 Cells

  2014cites this paper
• Food Functions Preventing Muscle Atrophy

  2014cites this paper
• Effect of colibacillosis or coccidiosis on expression of breast cancer resistance protein in small intestine and liver of chickens.

  2014cites this paper
• Identification et mécanisme d'action de modulateurs sélectifs du transporteur ABCG2 responsable de la chimiorésistance de cellules cancéreuses

  2014cites this paper
• A cell-permeable inhibitor to trap Gαq proteins in the empty pocket conformation.

  2014cites this paper
• Transport of 3-bromopyruvate across the human erythrocyte membrane

  2014cites this paper
• Computational insights into the active site of human breast cancer resistance protein ( BCRP / ABCG 2 ) : a similarity search approach

  2014cites this paper
• ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity

  2013cites this paper
• New structure–activity relationships of chalcone inhibitors of breast cancer resistance protein: polyspecificity toward inhibition and critical substitutions against cytotoxicity

  2013cites this paper
• Renal transporters in drug development.

  2013cites this paper
• Determinação da atividade antioxidante e do teor total de polifenol em amostras de chá de ervas comercializadas em sachets Determination of total antioxidant activity and total content of polyphenols in samples of tea leaves marketed in bags

  2013cites this paper
• The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP).

  2013cites this paper
• Predicting substrates of the human breast cancer resistance protein using a support vector machine method

  2013cites this paper
• Impact of ABC transporters, glutathione conjugates in MDR and their modulation by flavonoids: an overview

  2013cites this paper
• Development of New Breast Cancer Resistance Protein Inhibitors

  2013cites this paper
• Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies.

  2012cites this paper
• Polyphenols counteract tumor cell chemoresistance conferred by multidrug resistance proteins.

  2012cites this paper
• Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter.

  2012cites this paper
• Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.

  2012cites this paper
• Flavonoids and Drug Interactions

  2012cites this paper
• Methoxy stilbenes as potent, specific, untransported, and noncytotoxic inhibitors of breast cancer resistance protein.

  2012cites this paper